Aurobindo Pharma Limited — JV/Acquisition, 25-10-2024: Acquisition

Aurobindo Pharma has completed the acquisition of the remaining 49% equity shares of GLS Pharma Limited, making GLS a wholly owned subsidiary. This acquisition involved 5,90,361 equity shares at a purchase consideration of INR 22.5 crores, following a previous announcement made on September 18, 2024.